We are live on
!
Find out more
GCA
Greenwood Capital Associates Portfolio holdings
AUM
$1.02B
1-Year Est. Return
28.26%
This Fund
S&P 500
This Quarter
Est. Return
+4.49%
1 Year Est. Return
+28.26%
3 Year Est. Return
+81.29%
5 Year Est. Return
+95.78%
10 Year Est. Return
+421.94%
AUM
$397M
AUM Growth
+$8.31M
(+2.1%)
Cap. Flow
-$5.3M
Cap. Flow
% of AUM
-1.33%
Top 10 Holdings %
Top 10 Hldgs %
26.94%
Holding
208
New
42
Increased
62
Reduced
62
Closed
37
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$5.49M |
| 2 |
NVO
Novo Nordisk
NVO
|
+$4.25M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$4.17M |
| 4 |
iShares MSCI Global Gold Miners ETF
RING
|
+$4.15M |
| 5 |
Gilead Sciences
GILD
|
+$4.14M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$6.96M |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$6.06M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$5.8M |
| 4 |
Baker Hughes
BKR
|
+$5.25M |
| 5 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$4.68M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.49% |
| 2 | Communication Services | 10.26% |
| 3 | Technology | 9.58% |
| 4 | Consumer Discretionary | 8.95% |
| 5 | Industrials | 8.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Microsoft
MSFT
$3.69T
| $14.4M | 3.62% |
107,297
-3,837
| -3% | -$487K |
|
2
Walt Disney
DIS
$178B
| $13.8M | 3.46% |
98,552
-10,194
| -9% | -$1.35M |
|
3
Johnson & Johnson
JNJ
$617B
| $11M | 2.77% |
79,042
+937
| +1% | +$130K |
|
4
Vanguard FTSE Europe ETF
VGK
$31.2B
| $10.4M | 2.63% |
190,069
+10,700
| +6% | +$583K |
|
5
iShares Intermediate Government/Credit Bond ETF
GVI
$3.78B
| $10.2M | 2.57% |
91,065
+1,429
| +2% | +$158K |
|
6
State Street DoubleLine Total Return Tactical ETF
TOTL
$4.03B
| $10.2M | 2.57% |
207,790
+1,905
| +0.9% | +$92.3K |
|
7
Pfizer
PFE
$148B
| $9.59M | 2.41% |
233,209
+9,486
| +4% | +$377K |
|
8
JPMorgan Chase
JPM
$955B
| $9.45M | 2.38% |
84,500
+23,583
| +39% | +$2.6M |
|
9
Cisco
CSCO
$481B
| $9.1M | 2.29% |
166,185
-56,174
| -25% | -$3.1M |
|
10
Lowe's Companies
LOW
$122B
| $8.93M | 2.25% |
88,454
+1,105
| +1% | +$117K |
|
11
iShares Russell 3000 ETF
IWV
$20.3B
| $8.72M | 2.19% |
50,672
+170
| +0.3% | +$28.8K |
|
12
Mastercard
MA
$498B
| $8.63M | 2.17% |
32,626
-3,537
| -10% | -$885K |
|
13
Alphabet (Google) Class A
GOOGL
$4.41T
| $8.42M | 2.12% |
155,440
-34,280
| -18% | -$1.98M |
|
14
PepsiCo
PEP
$188B
| $8M | 2.01% |
61,032
-215
| -0.4% | -$27.6K |
|
|
15
iShares Core MSCI Total International Stock ETF
IXUS
$59.8B
| $7.97M | 2% |
135,847
-80,210
| -37% | -$4.68M |
|
16
Verizon
VZ
$194B
| $7.76M | 1.95% |
135,812
+54,647
| +67% | +$3.15M |
|
17
Honeywell
HON
$77.8B
| $7.71M | 1.94% |
46,887
-322
| -0.7% | -$51.2K |
|
|
RTN
18
DELISTED
Raytheon Company
RTN
| $7.04M | 1.77% |
40,492
+16,008
| +65% | +$2.88M |
|
19
Electronic Arts
EA
| $6.88M | 1.73% |
67,982
+33,860
| +99% | +$3.23M |
|
20
Walmart Inc
WMT
$896B
| $6.79M | 1.71% |
184,335
+1,536
| +0.8% | +$52.9K |
|
21
Vulcan Materials
VMC
$36.5B
| $6.66M | 1.68% |
48,495
+86
| +0.2% | +$11K |
|
22
VF Corp
VFC
$5.94B
| $6.63M | 1.67% |
75,886
-4,885
| -6% | -$421K |
|
23
Home Depot
HD
$350B
| $6.13M | 1.54% |
29,492
+609
| +2% | +$121K |
|
24
PayPal
PYPL
$50.3B
| $5.9M | 1.48% |
51,523
-1,109
| -2% | -$123K |
|
|
25
Merck
MRK
$317B
| $5.74M | 1.44% |
+71,722
| New | +$5.49M |
|
Similar funds
SVCP
EFM
CC
MSA
MAM
IAS
WA
GSIS
Greenwood Capital Associates's Q2 2019 Portfolio in Review
As of Q2 2019, Greenwood Capital Associates held 208 positions worth $397M, up 2.1% from $389M the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Greenwood Capital Associates's Q2 2019 filing shows 42 new, 62 increased, 62 reduced and 37 closed positions. Its largest new stake was Merck: 71,722 shares worth $5.74M. The largest sale was Bristol-Myers Squibb, an estimated $6.96M.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, down from 13% a quarter earlier, followed by Communication Services and Technology.
- Greenwood Capital Associates's largest Q2 2019 buy was Merck: 71,722 shares worth $5.74M.
- Greenwood Capital Associates added most to Electronic Arts in Q2 2019, an estimated $3.23M increase.
- Greenwood Capital Associates's biggest Q2 2019 reduction was iShares Core MSCI Emerging Markets ETF, cutting an estimated $6.06M.
- Greenwood Capital Associates fully exited Bristol-Myers Squibb in Q2 2019, selling an estimated $6.96M.
- Greenwood Capital Associates's ten largest holdings make up 27% of its $397M portfolio in Q2 2019.
- Greenwood Capital Associates opened 42 new positions and closed 37 in Q2 2019.
- Greenwood Capital Associates's portfolio value rose 2.1% quarter-over-quarter to $397M.
Based on Greenwood Capital Associates's 13F filing for Q2 2019, filed 13 Aug 2019.